SCHEMBL17058183

SCHEMBL17058183

CC(C)[S@@+]([O-])N1CCN(c2cnn(-c3ccccc3)c(=O)c2OC2CCCCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MCHR1 Q99705 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.40
▸ DCTPP1 Q9H773 4/20 0.40
▸ MAPT P10636 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ NPBWR1 P48145 3/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ GRM1 Q13255 1/20 0.36
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057807 0.92 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17058013 0.91 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17057912 0.91 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17057894 0.90 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17058465 0.89 POLB (0.43) SMN1; SMN2MCHR1POLBALDH1A1DCTPP1
SCHEMBL17058139 0.89 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17057963 0.89 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17058312 0.88 SMN1; SMN2 (0.40) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17057811 0.88 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2MCHR1LMNA
SCHEMBL17058121 0.88 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MCHR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback